The Asia Pacific In-vitro Fertilization Microscopes Market should witness market growth of 11.9% CAGR during the forecast period (2022-2028).
One of the most prevalent hormonal illnesses among women of reproductive age is a polycystic ovarian syndrome (PCOS). Women who come with infertility often have been diagnosed with PCOS. The three significant signs of polycystic ovarian syndrome are polycystic ovaries, excessive body or facial hair, and irregular menstrual periods. Increased PCOS prevalence in women may cause infertility, increasing the need for in-vitro fertilization to have children. A severe clinical issue is the rising incidence of infertility. Such causes as aberrant morphology reduced sperm concentration, and poor sperm motility might all be contributing factors.
Hence, rising rates of male infertility and more knowledge of it have led to increased use of medications, hormone treatment, and ART. Among the leading causes of male infertility include alcohol use, smoking, obesity, stress, and alterations in lifestyle. Governments of various nations have made steps to enhance how infertility-related therapies are reimbursed in the respective countries. Also, it is anticipated that patients would choose in-vitro fertilization more due to increased patient data security by regulatory standards defined by regulatory bodies.
The 'low fertility trap,'in which having fewer children results in lower expenditure on education and related services, is causing governments in the region's wealthier nations to increase anxiety. This situation makes it increasingly harder to increase birth rates. The drop in fertility rate brought on by changes in living habits and the tendency towards postponed pregnancies has increased the need for IVF procedures across China. Also, in the following years, the market for in-vitro fertilization microscopes will expand significantly in the Asia Pacific region due to the cheap cost of IVF therapy.
The China market dominated the Asia Pacific In-vitro Fertilization Microscopes Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $15,865.3 Thousands by 2028. The Japan market is estimated to grow a CAGR of 11.2% during (2022-2028). Additionally, The India market would display a CAGR of 12.6% during (2022-2028).
Based on End-user, the market is segmented into Clinical and Academic Research. Based on Type, the market is segmented into Embryo Microscope, Upright Microscopes, Stereo Microscopes and Inverted Microscopes. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hamilton Thorne, Inc. (Hamilton Thorne, Ltd.), Olympus Corporation, Leica Microsystems GmbH (Danaher Corporation), Carl Zeiss AG, Nikon Corporation, Linkam Scientific Instruments, Meiji Techno Co., Ltd., Euromex Microscopen B.V. (Euromex Optics Group B.V.), Labomed Europe B.V., and Narishige Group.
One of the most prevalent hormonal illnesses among women of reproductive age is a polycystic ovarian syndrome (PCOS). Women who come with infertility often have been diagnosed with PCOS. The three significant signs of polycystic ovarian syndrome are polycystic ovaries, excessive body or facial hair, and irregular menstrual periods. Increased PCOS prevalence in women may cause infertility, increasing the need for in-vitro fertilization to have children. A severe clinical issue is the rising incidence of infertility. Such causes as aberrant morphology reduced sperm concentration, and poor sperm motility might all be contributing factors.
Hence, rising rates of male infertility and more knowledge of it have led to increased use of medications, hormone treatment, and ART. Among the leading causes of male infertility include alcohol use, smoking, obesity, stress, and alterations in lifestyle. Governments of various nations have made steps to enhance how infertility-related therapies are reimbursed in the respective countries. Also, it is anticipated that patients would choose in-vitro fertilization more due to increased patient data security by regulatory standards defined by regulatory bodies.
The 'low fertility trap,'in which having fewer children results in lower expenditure on education and related services, is causing governments in the region's wealthier nations to increase anxiety. This situation makes it increasingly harder to increase birth rates. The drop in fertility rate brought on by changes in living habits and the tendency towards postponed pregnancies has increased the need for IVF procedures across China. Also, in the following years, the market for in-vitro fertilization microscopes will expand significantly in the Asia Pacific region due to the cheap cost of IVF therapy.
The China market dominated the Asia Pacific In-vitro Fertilization Microscopes Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $15,865.3 Thousands by 2028. The Japan market is estimated to grow a CAGR of 11.2% during (2022-2028). Additionally, The India market would display a CAGR of 12.6% during (2022-2028).
Based on End-user, the market is segmented into Clinical and Academic Research. Based on Type, the market is segmented into Embryo Microscope, Upright Microscopes, Stereo Microscopes and Inverted Microscopes. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hamilton Thorne, Inc. (Hamilton Thorne, Ltd.), Olympus Corporation, Leica Microsystems GmbH (Danaher Corporation), Carl Zeiss AG, Nikon Corporation, Linkam Scientific Instruments, Meiji Techno Co., Ltd., Euromex Microscopen B.V. (Euromex Optics Group B.V.), Labomed Europe B.V., and Narishige Group.
Scope of the Study
By End-user
- Clinical
- Academic Research
By Type
- Embryo Microscope
- Upright Microscopes
- Stereo Microscopes
- Inverted Microscopes
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Hamilton Thorne, Inc. (Hamilton Thorne, Ltd.)
- Olympus Corporation
- Leica Microsystems GmbH (Danaher Corporation)
- Carl Zeiss AG
- Nikon Corporation
- Linkam Scientific Instruments
- Meiji Techno Co., Ltd.
- Euromex Microscopen B.V. (Euromex Optics Group B.V.)
- Labomed Europe B.V.
- Narishige Group
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific In-vitro Fertilization Microscopes Market, by End User
1.4.2 Asia Pacific In-vitro Fertilization Microscopes Market, by Type
1.4.3 Asia Pacific In-vitro Fertilization Microscopes Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific In-vitro Fertilization Microscopes Market by End User
3.1 Asia Pacific Clinical Market by Country
3.2 Asia Pacific Academic Research Market by Country
Chapter 4. Asia Pacific In-vitro Fertilization Microscopes Market by Type
4.1 Asia Pacific Embryo Microscope Market by Country
4.2 Asia Pacific Upright Microscopes Market by Country
4.3 Asia Pacific Stereo Microscopes Market by Country
4.4 Asia Pacific Inverted Microscopes Market by Country
Chapter 5. Asia Pacific In-vitro Fertilization Microscopes Market by Country
5.1 China In-vitro Fertilization Microscopes Market
5.1.1 China In-vitro Fertilization Microscopes Market by End User
5.1.2 China In-vitro Fertilization Microscopes Market by Type
5.2 Japan In-vitro Fertilization Microscopes Market
5.2.1 Japan In-vitro Fertilization Microscopes Market by End User
5.2.2 Japan In-vitro Fertilization Microscopes Market by Type
5.3 India In-vitro Fertilization Microscopes Market
5.3.1 India In-vitro Fertilization Microscopes Market by End User
5.3.2 India In-vitro Fertilization Microscopes Market by Type
5.4 South Korea In-vitro Fertilization Microscopes Market
5.4.1 South Korea In-vitro Fertilization Microscopes Market by End User
5.4.2 South Korea In-vitro Fertilization Microscopes Market by Type
5.5 Singapore In-vitro Fertilization Microscopes Market
5.5.1 Singapore In-vitro Fertilization Microscopes Market by End User
5.5.2 Singapore In-vitro Fertilization Microscopes Market by Type
5.6 Malaysia In-vitro Fertilization Microscopes Market
5.6.1 Malaysia In-vitro Fertilization Microscopes Market by End User
5.6.2 Malaysia In-vitro Fertilization Microscopes Market by Type
5.7 Rest of Asia Pacific In-vitro Fertilization Microscopes Market
5.7.1 Rest of Asia Pacific In-vitro Fertilization Microscopes Market by End User
5.7.2 Rest of Asia Pacific In-vitro Fertilization Microscopes Market by Type
Chapter 6. Company Profiles
6.1 Hamilton Thorne, Inc. (Hamilton Thorne, Ltd.)
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Acquisition and Mergers:
6.2 Olympus Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Recent strategies and developments:
6.2.4.1 Partnerships, Collaborations, and Agreements:
6.3 Leica Microsystems GmbH (Danaher Corporation)
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Carl Zeiss AG
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.5 Nikon Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Linkam Scientific Instruments
6.6.1 Company Overview
6.7 Meiji Techno Co., Ltd.
6.7.1 Company Overview
6.8 Euromex Microscopen B.V. (Euromex Optics Group B.V.)
6.8.1 Company Overview
6.9 Labomed Europe B.V.
6.9.1 Company Overview
6.10. Narishige Group
6.10.1 Company Overview
Companies Mentioned
- Hamilton Thorne, Inc. (Hamilton Thorne, Ltd.)
- Olympus Corporation
- Leica Microsystems GmbH (Danaher Corporation)
- Carl Zeiss AG
- Nikon Corporation
- Linkam Scientific Instruments
- Meiji Techno Co., Ltd.
- Euromex Microscopen B.V. (Euromex Optics Group B.V.)
- Labomed Europe B.V.
- Narishige Group
Methodology
LOADING...
